Early Detection of Head and Neck Cancer Gets a Boost: Vigilant Biosciences Launches First-of-its-kind OncAlert Labs OraMark Test in the United States

Early Detection of Head and Neck Cancer Gets a Boost: Vigilant Biosciences Launches First-of-its-kind OncAlert Labs OraMark Test in the United States June 6, 2016 First quantitative laboratory-developed test to accurately measure a tumor-initiating and stem cell–associated biomarker for head and neck cancer in an oral rinse Vigilant Biosciences Inc. (Fort Lauderdale, Florida), a developer

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2